The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.
ATC code A: Alimentary tract and metabolism is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.
Alimentary Tract And Metabolism
Oral drops solution – (10.000 UI + 10.000 UI) / ml
Tablets - 500 mg
Tablets - 5mg
Solution for injection - (0.1%) 1 mg/1 ml
Sugar coated tablets - 10 mg
Buskolamin contains as active substance hyoscine butylbromide. Hyoscine butylbromide is a quaternary ammonium salt. This drug, due to its anticholinergic action, possesses antispasmodic properties and it is used to relieve smooth muscle spasms.
Buskolamin 10 mg sugar-coated tablets are indicated in:
Solution for injection - 20 mg / ml
Buskolamin contains as active substance hyoscine butylbromide. Hyoscine butylbromide is a quaternary ammonium salt. This drug, due to its anticholinergic action, possesses antispasmodic properties and it is used to relieve smooth muscle spasms.
Buskolamin 20 mg/ml solution for injection is indicated:
during diagnostic procedures (radiography or endoscopy).
Solution for injection - 40 mg / 2 ml
Solution with drops for local use - 100%
Eugenol has analgesic and antiseptic action and produces local anesthesia.
The bacteriostatic action of Eugenol is against: Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida albicans.
It is used in stomatology, frequently mixed with zinc oxide.
It is used for calming toothaches (a dyed cotton is placed inside the cavity of the affected tooth), in temporary dental fillings with zinc oxide and as a constituent in oral hygiene preparations.
It may be used as flavoring agent.
Clove essence has antihelmintic properties.
Tablets - 5 mg
Solution for injection - (10%) 1 g/10 ml
Tablets - 500 mg
Calcium is a mineral element necessary to maintain electrolytic balance and proper functioning of many regulatory mechanisms. Calcium insufficiency is associated with neuromuscular disorders and bone demineralisation. Calcium increases the effectiveness of leukocytes, increases phagocytosis and has an exudative effect on the capillaries during cold weather. Taking calcium increases its concentration in serum and in the whole body. 99% of calcium in the body is bound with phosphates in bones, mainly as hydroxyapatite.
Kalcium glukonat is indicated as additional treatment to the osteoporosis of different ethiology (postmenopausal osteoporosis, senile osteoporosis, osteoporosis induced by corticosteroids, gastrectomy or immobilization); prophylaxis of bone demineralisation before, during or after menopause; additional medication in rickets or osteomalacia; latent tetany (in acute cases calcium gluconate is used parenterally); in case of increased needs for calcium during pregnancy and breast feeding, as well as in the period of growth (childhood, adolescence); allergic condition (as additional treatment).
Tablets - 2 mg
Tablets - 500 mg
Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).
Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.
In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.
Film-coated tablets - 1000 mg
Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).
Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.
In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.
Tablets - 850 mg
Metformine is an oral antidiabetic which is not chemically or pharmacologically related to sulfonylurea derivatives. Metformine improves glucose tolerance in non-insulin-dependent diabetes mellitus by reducing basal and after-meal blood glucose levels. Metformine also reduces hepatic glucose production, intestinal glucose absorption and improves insulin sensitivity (increases peripheral glucose uptake).
Metformine is indicated in non-insulin-dependent diabetes mellitus when treatment by diet modification alone has not been effective and when the patient is overweight. Metformine may be used alone as initial treatment or in combination with a sulfonylurea derivative.
In insulin-dependent diabetes mellitus, Metformine may be used as adjunctive treatment in patients whose symptoms are difficult to manage.
Film coated tablets - 180 mg
Solution - 10 %
Rectal solution - 5 mg/2.5 ml
Tablets - 0.5 mg
Tablets - 25 mg
